AJP - GI AJP: Endocrinology and Metabolism
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Am J Physiol Gastrointest Liver Physiol (September 29, 2005). doi:10.1152/ajpgi.00348.2005
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
290/2/G361    most recent
00348.2005v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Otani, T.
Right arrow Articles by Dannenberg, A. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Otani, T.
Right arrow Articles by Dannenberg, A. J.
Submitted on July 26, 2005
Accepted on September 26, 2005

Levels of NAD+-Dependent 15-Hydroxyprostaglandin Dehydrogenase are Reduced in Inflammatory Bowel Disease. Evidence for Involvement of TNF-{alpha}

Taisuke Otani1, Kentaro Yamaguchi1, Ellen Scherl2, Baoheng Du2, Hsin-Hsiung Tai3, Melanie Greifer4, Lydia Petrovic5, Takiko Daikoku6, Sudhansu K. Dey6, Kotha Subbaramaiah2, and Andrew J. Dannenberg2*

1 Department of Medicine, Weill Medical College of Cornell University, New York, New York, USA; Department of Surgery, Tokyo Women's Medical University Daini Hospital, Tokyo, Japan
2 Department of Medicine, Weill Medical College of Cornell University, New York, New York, USA
3 Department of Pharmaceutical Sciences, College of Pharmacy, University of Kentucky, Lexington, Kentucky, USA
4 Department of Pediatrics, Weill Medical College of Cornell University, New York, New York, USA
5 Department of Pathology, Weill Medical College of Cornell University, New York, New York, USA
6 Departments of Pediatrics and Cell & Developmental Biology, Vanderbilt University Medical Center, Nashville, Tennessee, USA

* To whom correspondence should be addressed. E-mail: ajdannen{at}med.cornell.edu.

Increased amounts of PGE2 have been detected in the inflamed mucosa of patients with inflammatory bowel disease (IBD). This increase has been attributed to enhanced synthesis rather than reduced catabolism of PGE2. 15-Hydroxyprostaglandin dehydrogenase (15-PGDH) plays a major role in the catabolism of PGE2. In this study, we investigated whether amounts of 15-PGDH were altered in inflamed mucosa from patients with IBD. Amounts of 15-PGDH protein and mRNA were markedly reduced in inflamed mucosa from patients with Crohn's disease and ulcerative colitis. In situ hybridization demonstrated that 15-PGDH was expressed in normal colonic epithelium but was virtually absent in inflamed colonic mucosa from IBD patients. Because of the importance of TNF-{alpha} in IBD, we also determined the effects of TNF-{alpha} on the expression of 15-PGDH in vitro. Treatment with TNF-{alpha} suppressed the transcription of 15-PGDH in human colonocytes, resulting in reduced amounts of 15-PGDH mRNA, protein and enzyme activity. In contrast, TNF-{alpha} induced two enzymes (COX-2, mPGES-1) that contribute to increased synthesis of PGE2. Overexpressing 15-PGDH blocked the increase in PGE2 production mediated by TNF-{alpha}. Taken together, these results suggest that reduced expression of 15-PGDH contributes to the elevated levels of PGE2 found in inflamed mucosa of IBD patients. The decrease in amounts of 15-PGDH in inflamed mucosa can be explained at least, in part, by TNF-{alpha}-mediated suppression of 15-PGDH transcription.




This article has been cited by other articles:


Home page
Cancer Prevention ResearchHome page
S. D. Markowitz
Colorectal Neoplasia Goes with the Flow: Prostaglandin Transport and Termination
Cancer Prevention Research, July 1, 2008; 1(2): 77 - 79.
[Full Text] [PDF]


Home page
Cancer Res.Home page
J. R. Mann, M. G. Backlund, F. G. Buchanan, T. Daikoku, V. R. Holla, D. W. Rosenberg, S. K. Dey, and R. N. DuBois
Repression of Prostaglandin Dehydrogenase by Epidermal Growth Factor and Snail Increases Prostaglandin E2 and Promotes Cancer Progression.
Cancer Res., July 1, 2006; 66(13): 6649 - 6656.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Visit Other APS Journals Online
Copyright © 1977 by the American Physiological Society.